Viewing Study NCT06752694

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2026-03-06 @ 1:24 PM
Study NCT ID: NCT06752694
Status: RECRUITING
Last Update Posted: 2025-09-30
First Post: 2024-12-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
Sponsor: Fred Hutchinson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Aplastic Anemia View
Keywords: